Canada's Loblaw administers COVID-19 vaccines at Ontario pharmacies

Published 2021-03-10, 02:05 p/m
© Reuters. FILE PHOTO: A test tube labelled with the Vaccine is seen in front of an AstraZeneca logo in this illustration
PFE
-
AZN
-

(Reuters) - Canada's Loblaw Cos Ltd said on Wednesday it had started administering AstraZeneca (NASDAQ:AZN) Plc's COVID-19 vaccine at 160 pharmacies it owns in Ontario, as the country works to curb the spread of the new coronavirus.

The parent of Shoppers Drug Mart chain said its pharmacies in Toronto, Windsor-Essex and Kingston had started inoculating people aged between 60 and 64 as part of a provincial trial.

Last week, Loblaw said more than 40-owned pharmacies in Alberta had started administering Pfizer Inc (NYSE:PFE)'s vaccine to people over the age of 75.

The retail chain offers full-service pharmacies and professional care in more than 1,800 locations in 10 provinces and 2 territories, including in Shoppers Drug Mart and PharmaPrix stores.

Several U.S. pharmacy chains have been administering COVID-19 vaccines since February, as President Joe Biden had set a goal of delivering 100 million vaccine doses in his first 100 days in office.

© Reuters. FILE PHOTO: A test tube labelled with the Vaccine is seen in front of an AstraZeneca logo in this illustration

Walgreens said on Tuesday it had provided about 5 million vaccinations to Americans.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.